Ireland· IE-PA-EU/1/22/1703/001
Pluvicto 1000 MBq/mL solution for injection/infusion
A lutetium (177lu) vipivotide tetraxetan product containing lutetium (177lu) vipivotide tetraxetan, registered in Ireland by Novartis Europharm Limited. The same ATC class is registered in 9 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Lutetium (177lu) vipivotide tetraxetan is registered in 9 of 19 countries.
Countries holding a registration under ATC V10XX05 (lutetium (177lu) vipivotide tetraxetan), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Lutetium (177lu) vipivotide tetraxetan · ATC V10XX05
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Lutetium (177Lu) vipivotide tetraxetan
- Manufacturer
- Novartis Europharm Limited
- Country
- Ireland (IE)
- ATC code
- V10XX05
- ATC class
- Lutetium (177Lu) vipivotide tetraxetan
- Defined daily dose
- 176 MBq, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/22/1703/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lutetium (177lu) vipivotide tetraxetan in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandPluvicto 1000 MBq/ml, Injektions-/InfusionslösungNovartis Pharma Schweiz AG
- United StatesPLUVICTONovartis Pharmaceuticals Corporation
- CzechiaPLUVICTONovartis Europharm Limited, Dublin
- FinlandPluvictoNovartis Europharm Limited
- BelgiumPluvicto 1000 MBq/mlNovartis Europharm
- United KingdomPluvicto 7,400MBq/7.5-12.5ml solution for injection vialsNovartis Pharmaceuticals UK Ltd
- IcelandPluvictoNovartis Europharm Limited*
- NetherlandsPluvicto 1.000 MBq/ml oplossing voor injectie/infusieNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Pluvicto
- Liechtenstein · Pluvicto
- Norway · Pluvicto
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f58aee3f-711b-41bc-96b6-2eea8b790815 GET /v1/drugs/f58aee3f-711b-41bc-96b6-2eea8b790815?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection/infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"V10XX",
"V10XX05"
],
"strength": null,
"pa_number": "EU/1/22/1703/001",
"substances": [
"Lutetium (177Lu) vipivotide tetraxetan"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "09/12/2022",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about lutetium (177lu) vipivotide tetraxetan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.